Drug recall · December 16, 2020
Dexmedetomidine HCl in 0.9% Sodium Chloride Injection recall
Why: Cross Contamination with other products: trace amounts of lidocaine
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg / 50 mL (4 mcg / mL), 50 mL Single Dose Bottle, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC 63323-671-05
- Lots / codes
Lot #: 6123925
- Quantity
- 13,525 bottles
- Company
- Fresenius Kabi USA, LLC, Lake Zurich, IL
- Distribution
- USA Nationwide
- Initiated
- November 17, 2020 · Voluntary: Firm initiated
- Classified
- December 8, 2020
- Reported
- December 16, 2020
- Ended
- September 12, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Dexmedetomidine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.